CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...